Impact of age on survival according to molecular tumor findings in children and adolescents with soft-tissue and bone sarcoma: The BIOSCA project.
Fiche publication
Date publication
juin 2023
Journal
Cancer epidemiology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DESANDES Emmanuel, Dr LACOUR Brigitte
Tous les auteurs :
Desandes E, Lapouble E, Lacour B, Guissou S, Goujon S, Defachelles AS, Marechal V, Gaspar N, Gomez-Mascard A, Karanian M, Marec-Berard P, Minard-Colin V, Orbach D, Tabone MD, Delattre O, Pierron G
Lien Pubmed
Résumé
Adolescents (15-19 years) with sarcoma are known to have significantly worse survival than children (0-14 years). One possible reason may be that the adolescent sarcomas exhibit specific biological characteristics resulting in differences in clinical presentation and treatment resistance behaviors. The BIOSCA project aims to further explore these age-related differences in survival accounting for molecular tumor characteristic in children and adolescents with sarcoma.
Mots clés
Adolescents, Children, Molecular biomarker, Sarcoma, Survival
Référence
Cancer Epidemiol. 2023 06 23;:102398